Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Recruiting · NCT07521332 · Registry updated 2026-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis | Ascites, Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, digestive system disorder, esophageal disorder, esophageal varices, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension, portal vein thrombosis | Recruiting | Phase 4 | 2026-04-09 | NCT07521332 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Asian Institute Of Medical Sciences | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asian Institute of Medical Sciences | Hyderābād | Pakistan | 2 |